You have 9 free searches left this month | for more free features.

City

Condition

B-cell Non-Hodgkins Lymphoma (B-NHL) (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Regeneron Pharmaceuticals (1)

Collaborator

Intervention

odronextamab (1)

regn5837 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

regn5837

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

Not yet recruiting

B-cell Non-Hodgkins Lymphoma (B-NHL)

Odronextamab
REGN5837

(no location specified)

Jan 5, 2023